Tom J. Snijders

Utrecht, UT 3584CX, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 16, 2026

The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.

The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.

Journal: Neuro-oncology

Published: May 05, 2026

Exploring brain-glioma interaction: Effect of neuroligin-3 expression on neurocognitive functioning is independent from epilepsy.

Exploring brain-glioma interaction: Effect of neuroligin-3 expression on neurocognitive functioning is independent from epilepsy.

Journal: Neuro-oncology advances

Published: February 03, 2026

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Journal: PloS one

Published: January 12, 2026

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Journal: The Lancet. Haematology

Published: January 08, 2026

Near complete response recurrent glioblastoma after treatment with [131I]-Iodofalan.

Near complete response recurrent glioblastoma after treatment with [131I]-Iodofalan.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 04, 2025

Bevacizumab for symptomatic cerebral radiation necrosis after radiation of high-grade glioma or brain metastases - when and for whom?

Bevacizumab for symptomatic cerebral radiation necrosis after radiation of high-grade glioma or brain metastases - when and for whom?

Journal: Neuro-oncology practice

Published: October 13, 2025

Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology.

Patient perspectives on diagnostic uncertainty and novel diagnostic tests in neuro-oncology.

Journal: Neuro-oncology practice

Published: October 03, 2025

Efficacy of Intra-arterial [177Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma.

Efficacy of Intra-arterial [177Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma.

Journal: Journal of neuro-oncology

Published: August 25, 2025

Functional outcome after repeat surgery of tumor progression or treatment-associated changes in high-grade glioma: Clinical and radiological predictors.

Functional outcome after repeat surgery of tumor progression or treatment-associated changes in high-grade glioma: Clinical and radiological predictors.

Journal: Neuro-oncology practice

Published: August 05, 2025

Bayesian adaptive randomized trial of blended cognitive behavioral therapy for severe fatigue in stable diffuse glioma.

Bayesian adaptive randomized trial of blended cognitive behavioral therapy for severe fatigue in stable diffuse glioma.

Journal: Neuro-oncology

Published: July 21, 2025

Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma.

Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma.

Journal: Neuro-oncology

Published: July 21, 2025

Showing 1-12 of 101

Last Updated: 09/26/2026